NCT00828464View on ClinicalTrials.gov

Study to Evaluate Safety, Efficacy and Tolerability of Clobetasol Propionate for Chronic Hand Dermatitis

PHASE4CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions

Hand Dermatosis

Interventions

DRUG

clobetasol propionate

Clobetasol propionate. The study product will be applied topically twice a day (morning and evening) for 14 days of treatment.

Trial Locations (1)

40217

Physicians Skin Care, Louisville

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

Stiefel, a GSK Company

INDUSTRY